Analyses of Bcl-2, Survivin, and CD44v6 expressions and human papillomavirus infection in cervical carcinomas

References

• Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72–81
   PubMed Web of Science ®Google Scholar
• Pilch H, Gunzel S, Schaffer U, Tanner B, Brockerhoff P, Maeurer M, et al. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer-free pelvic lymph nodes: correlation with clinico-pathological parameters and prognostic significance. Zentralbl Gynakol 2001; 123: 91–101
   PubMedGoogle Scholar
• Rolon PA, Smith JS, Munoz N, Klug SJ, Herrero R, Bosch X, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 486–91
   PubMed Web of Science ®Google Scholar
• DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virology 2003; 77: 1551–63
   PubMedGoogle Scholar
• Isacson C, Kessis TD, Hedrick L, Cho KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996; 56: 669–74
   PubMed Web of Science ®Google Scholar
• Nair P, Nair KM, Jayaprakash PG, Pillai MR. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res 1999; 5: 95–103
   PubMedGoogle Scholar
• Li Z, Takeuchi S, Ohara N, Maruo T. Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma. Int J Clin Oncol 2003; 8: 83–9
   PubMedGoogle Scholar
• Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T, et al. Immunohistochemical localization of Survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 2002; 117: 738–44
   PubMed Web of Science ®Google Scholar
• Costa S, Terzano P, Bovicelli A, Martoni A, Angelelli B, Santini D, et al. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecol Oncol 2001; 80: 67–73
   PubMedGoogle Scholar
• Tokumo K, Kodama J, Seki N, Miyagi Y, Yoshinouchi M, Kudo T. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Eur J Cancer 1998; 34: 2107–11
   PubMedGoogle Scholar
• Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745–7
   PubMed Web of Science ®Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244–65
   PubMed Web of Science ®Google Scholar
• Koromilas AE, Li S, Matlashewski G. Control of interferon signalling in human papillomavirus infection. Cytokine Growth Factor Rev 2001; 12: 157–70
   PubMed Web of Science ®Google Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a world perspective. J of the National Cancer Inst 1995; 87: 796–802
   PubMed Web of Science ®Google Scholar
• Blankenberg FG. Recent advances in the imaging of programmed cell death. Curr Pharm Des 2004; 10: 1457–67
   PubMedGoogle Scholar
• Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, Hamdy FC. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation. Prostate 1998; 37: 223–9
   PubMed Web of Science ®Google Scholar
• Arai T, Kino I. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 1995; 176: 37–44
   PubMed Web of Science ®Google Scholar
• Zanotti S, Fisseler-Eckhoff A, Mannherz HG. Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma. Gynecol Oncol 2003; 89: 376–84
   PubMedGoogle Scholar
• Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, et al. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 2000; 77: 129–36
   PubMedGoogle Scholar
• Knowlton K, Mancini M, Creason S, Morales C, Hockenbery D, Anderson BO. Bcl-2 slows in vitro breast cancer growth despite its anti-apoptotic effect. J Surg Res 1998; 76: 22–6
   PubMed Web of Science ®Google Scholar
• Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, et al. Expression of Survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 2001; 32: 119–25
   PubMed Web of Science ®Google Scholar
• Kim HS, Shiraki K, Park SH. Expression of Survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 2002; 22: 805–8
   PubMed Web of Science ®Google Scholar
• Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anti-cancer drugs. Cancer Res 1998; 58: 5315–20
   PubMed Web of Science ®Google Scholar
• Saitoh Y, Yaginuma Y, Ishikawa M. Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol 1999; 15: 137–41
   PubMed Web of Science ®Google Scholar
• Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005; 124: 113–21
   PubMedGoogle Scholar
• Darai E, Walker-Combrouze F, Benifla JL, Henin D, Feldmann G, Madelenat P, et al. E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: comparison between HIV-positive and HIV-negative women and correlation with HPV status. Gynecol Oncol 2000; 76: 56–62
   PubMedGoogle Scholar
• Biesold C, Kohler U, Horn LC, Bilek K, Kade R, Emmert C. CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma: an immunocytochemical study of 94 cases. Arch Gynecol Obstet 1995; 256: 147–53
   PubMedGoogle Scholar
• Ahmed MI, Salahy EE, Fayed ST, El-Hefnawy NG, Khalifa A. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001; 34: 491–8
   PubMed Web of Science ®Google Scholar